According to the latest report by IMARC Group, titled “Bifurcation Lesions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global bifurcation lesions market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Report Sample: https://www.imarcgroup.com/bifurcation-lesions-market/requestsample

A bifurcation lesion represents the narrowing of the coronary artery adjacent to the origin of a significant side branch (SB). It primarily include the development of atherosclerotic plaque from turbulent blood flow and high shear stress. This is treated using different techniques like analysis, procedure duration, X-ray exposure, long-term follow-up, etc. Moreover, three-dimensional (3D) angiography and multi-slice computed tomography help in measuring the bifurcation angles. Several advancements in devices, imaging, vascular access, adjunctive pharmacotherapy, etc., ensure the management of complex cases of bifurcation lesions.

Checkout- https://www.imarcgroup.com/checkout?id=4003&method=1

The rising occurrences of coronary artery disease (CAD), particularly among the geriatric population, are escalating the risks of developing bifurcation lesions, thereby propelling the global market. Additionally, increasing healthcare insurance coverage and numerous initiatives undertaken by government bodies for reimbursement of medical expenses are further bolstering the market growth. Besides this, the expanding medical tourism sector and the growing need for minimally invasive (MI) procedures are also augmenting the demand for bifurcation lesions. This, in turn, is stimulating the improvement of healthcare infrastructures around the globe, thereby supporting the market growth. Various other factors, such as ongoing research on novel treatment techniques, faster clinical trials, increasing healthcare expenditures, etc., will continue to drive the market growth over the forecast period.

Bifurcation Lesions Market 2021-2026 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the global bifurcation lesions market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Boston Scientific Corporation

  • Cardinal Health

  • Medtronic plc

  • Spectranetics (Koninklijke Philips N.V.)

  • Terumo Corporation

Key Market Segmentation:

The report has segmented the global bifurcation lesions market on the basis of types, application and region.

Breakup by Types:

  • One-Stent

  • Two-Stent

Breakup by Application:

  • Coronary Vascular

  • Peripheral Vascular

Breakup by Region:

  • North America

  • Asia-Pacific

  • Europe

  • Latin America

  • Middle East and Africa

Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/bifurcation-lesions-market

Key highlights of the report:            

  • Market Performance (2015-2020)

  • Market Outlook (2021-2026)

  • Industry Trends

  • Market Drivers and Success Factors

  • The Impact of COVID-19 on the Global Market

  • Value Chain Analysis

  • Structure of the Global Market

  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us                              

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800